Related Experiment Video
Updated: Jul 28, 2025
Analysis of Embryonic and Larval Zebrafish Skeletal Myofibers from Dissociated Preparations
Published on: November 13, 2013
Effect of caldesmon mutations in the development of zebrafish embryos
Verneri Virtanen1, Kreetta Paunu1, Saana Niva1
1Cancer Research Unit, Institute of Biomedicine, FICAN West Cancer Center Laboratory, University of Turku, Turku University Hospital, Kiinamyllynkatu 10, 20520, Turku, Finland.
Abstract:
Cancer is a profound medical concern and better treatments are needed for cancer patients. Therefore, new cancer targets are constantly being studied. These targets need not only be relevant for cancer progression, but their modulation needs to be tolerated reasonably well by the host. Caldesmon is one of these proposed novel targets for cancer therapy. Therefore, we analyzed effects of caldesmon mutations in normal development using genetically modified zebrafish embryos. We analyzed mutations in both zebrafish caldesmon genes, cald1a and cald1b and analyzed effects of either mutation alone or as in combination in double homozygous embryos using molecular, morphological and functional analyses. The effects of caldesmon mutations were mild and the gross development of zebrafish embryos was normal. The caldesmon mutant embryos had, however, alterations in response to light-stimulus in behavioural assays. Taken together, the effects of caldesmon mutations in the development of zebrafish embryos were reasonably well tolerated and did not indicate significant concerns for caldesmon being a potential target for cancer therapy.
Insights
Caldesmon mutations in zebrafish development showed mild effects, with normal gross development but altered light-response behaviors. These findings suggest caldesmon is a potentially safe target for cancer therapy.
Area of Science:
- Developmental biology
- Cancer research
- Genetics
Background:
- Novel cancer targets are crucial for improved patient treatments.
- Caldesmon is being investigated as a potential therapeutic target in cancer.
- Target modulation must be well-tolerated by the host for clinical viability.
Purpose of the Study:
- To investigate the developmental effects of caldesmon gene mutations in zebrafish.
- To assess the safety and tolerability of targeting caldesmon during normal development.
Main Methods:
- Utilized genetically modified zebrafish embryos with mutations in caldesmon genes (cald1a and cald1b).
- Analyzed effects of single and combined homozygous mutations using molecular, morphological, and functional assays.
- Conducted behavioral assays to evaluate responses to stimuli.
Main Results:
- Caldesmon mutations resulted in mild developmental effects, with overall normal gross morphology in zebrafish embryos.
- Mutant embryos exhibited alterations in behavioral responses to light stimuli.
- The observed effects were generally well-tolerated during embryonic development.
Conclusions:
- Caldesmon mutations do not appear to cause significant developmental abnormalities in zebrafish.
- The tolerability of caldesmon mutations during development supports its potential as a cancer therapy target.
- Further research is warranted to fully elucidate caldesmon's role in cancer and its therapeutic potential.
